Taiwan Vaccine’s Push For Acceptance
Taiwan’s homegrown vaccine has completed the latest phase of its medical trials, pushing it closer to international acceptance. On Monday, Medigen announced the completion of Phase 3 trials in Paraguay. The vaccine was rolled out for public use in Taiwan in August, but along with fighting variants, Medigen is also battling skepticism and questions about a lack of data.
